Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | -1.58% | +0.27% | +77.25% |
May. 03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
May. 02 | Geron Shares Decline After Q1 Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.25% | 2.22B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.88% | 21.93B | |
-12.15% | 22.34B | |
-5.43% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- GERN Stock
- News Geron Corporation
- Geron : Completes Patient Enrollment in Phase 3 Trial of Imetelstat